NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Cara Therapeutics Inc. (NASDAQ: CARA), Uniqure NV (NASDAQ: QURE) and Baozun Inc. (NASDAQ: BZUN). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
OREX Research Package: http://www.traders-choice.com/pdf?s=OREX
CARA Research Package: http://www.traders-choice.com/pdf?s=CARA
QURE Research Package: http://www.traders-choice.com/pdf?s=QURE
BZUN Research Package: http://www.traders-choice.com/pdf?s=BZUN
============
Highlights from today's reports include:
On Monday, November 23, 2015, the NASDAQ Composite ended at 5,102.48, down 0.05%, the Dow Jones Industrial Average edged 0.17% lower, to finish the day at 17,792.68, and the S&P 500 closed at 2,086.59, down 0.12%.
- Orexigen Therapeutics Inc.'s stock added 2.10% to close Monday's session at USD 2.43. The company's shares oscillated between USD 2.36 and USD 2.48 in trade during the day. The stock recorded a trading volume of 1.82 million shares, which was below its 50-day daily average volume of 3.35 million shares and its 52-week average volume of 3.53 million shares. However, over the last five days Orexigen Therapeutics Inc.'s shares have declined by 3.19% and in the past one month the stock has lost 15.33%. In addition, over the last three months the stock has lost 12.27% and year to date the shares have shed 59.90%. The stock is trading at a price to book ratio of 7.48 which compares to a historical PB ratio close to 33.48. Additionally, the stock is trading at a price to sales ratio of 7.03. Furthermore, the shares of the company have a Relative Strength Index of 41.64.
- Cara Therapeutics Inc.'s stock advanced 0.76% to close Monday's session at USD 15.84. The share price vacillated between USD 15.24 and USD 16.23 during the day. The stock recorded a trading volume of 0.28 million shares, which was below its 50-day daily average volume of 0.30 million shares but above its 52-week average volume of 0.27 million shares. Over the last three days Cara Therapeutics Inc.'s shares have advanced 0.83% and in the past one week the stock has moved up 3.39%. Moreover, in the last six months the stock has gained 61.30% and year to date the shares have picked up 58.88%. The stock of the company is trading above its 20-day and 200-day simple moving averages by 2.36% and 13.42%, respectively. However, the stock is trading below its 50-day simple moving average by 0.67%. Additionally, the stock is trading at a price to book ratio of 3.55.
- Uniqure NV's stock edged higher by 4.62% to close Monday's session at USD 19.26. The company's shares oscillated between USD 18.12 and USD 19.37 in trade during the day. The stock recorded a trading volume of 0.34 million shares, which was below its 50-day daily average volume of 0.37 million shares but above its 52-week average volume of 0.27 million shares. Over the last three days Uniqure NV's shares have advanced 6.29% and in the past one week the stock has moved up 10.37%. However, over the last three months the stock has lost 18.73% and in the past six months the shares have shed 27.13%. The stock of the company is trading below its 50-day and 200-day simple moving averages by 8.05% and 23.22%, respectively. However, the stock is trading above its 20-day simple moving average by 3.67%. Furthermore, the shares have a Relative Strength Index of 49.64.
- The stock of Baozun Inc. gained 4.87% to close Monday's session at USD 7.97. The shares of the company moved in the range of USD 7.58 and USD 8.17 during the day. A trading volume of 0.53 million shares was recorded, which was lower than its 150-day daily average volume of 0.57 million shares and its 52-week average volume of 0.65 million shares. Over the last five days Baozun Inc.'s shares have advanced 25.51% and in the past one month the stock has gained a momentum of 30.02%. Additionally, over the last three months the stock has advanced 69.94% while in the past six months the shares have registered a loss of 28.07%. The stock of the company has been exhibiting some positive momentum and is trading above its 50-day and 200-day simple moving averages by 28.79% and 2.53%, respectively. Furthermore, the stock is trading at a price to book ratio of 1.13 and a price to sales ratio of 1.31.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the “Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice